Serious Game-based Intervention for Mild Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests how well a set of cognitive training games called Neuro-World can help people with mild cognitive impairment, which involves a decline in memory and thinking skills. Participants will either play these games at home or refrain from any cognitive training to determine if the games improve cognitive abilities. It suits those with mild cognitive issues who can use a tablet and have computer access for online sessions. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance cognitive health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this game-based intervention is safe for individuals with mild cognitive impairment?
Research shows that games like Neuro-World are generally safe for people with mild memory problems. Studies have found that these games usually do not cause harm. Designed to improve memory and focus, Neuro-World is used on a tablet. No major reports of negative effects have emerged from using these games, suggesting they are well-tolerated by users.12345
Why are researchers excited about this trial?
Neuro-World is unique because it uses a game-based approach to tackle mild cognitive impairment, which is different from traditional treatments like medication or cognitive therapy. This digital intervention is exciting because it can be easily accessed from home, making it more convenient for participants. Plus, by engaging users through gameplay, it may enhance motivation and adherence to the treatment, potentially leading to better cognitive outcomes. Researchers are eager to see if this fun and interactive method can provide effective cognitive benefits.
What evidence suggests that Neuro-World cognitive training games are effective for mild cognitive impairment?
Research shows that serious games, like Neuro-World, can improve thinking skills in people with mild memory problems. In this trial, participants in the Game Intervention arm will play Neuro-World for 30 minutes per day, twice a week for 12 weeks. Earlier studies demonstrated that Neuro-World improved mental abilities in people who had a stroke, suggesting it might benefit others as well. These games are designed to boost memory and focus, which are often affected by memory issues. Early results indicate that regular play can enhance memory and focus. This offers hope to those with mild memory problems who wish to maintain or improve their mental sharpness.12346
Who Is on the Research Team?
Sunghoon I Lee, PhD
Principal Investigator
University of Massachusetts, Amherst
Are You a Good Fit for This Trial?
This trial is for people over 55 with mild cognitive issues, scoring between 17 and 25 on the MoCA test. They must be able to use a computer for online games and assessments. It's not suitable for those with major depression, certain neurological conditions, severe hearing or vision loss, or significant arm impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention Period
Participants self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week for 12 weeks in the home setting
No-Intervention Period
Participants do not engage in any therapist-supervised cognitive therapies
Follow-up
Participants are monitored for safety and effectiveness after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Neuro-World
Trial Overview
The study tests 'Neuro-World' cognitive training games designed to help brain function in patients with mild cognitive impairment. Participants will play these games at home and communicate via videoconferencing for assessments.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Study participants play Neuro-World 30 minutes per day, twice a week for 12 weeks in your home settings (24 times).
Study participants do not engage in any cognitive training.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Amherst
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborator
Université de Montréal
Collaborator
Published Research Related to This Trial
Citations
Study Details | NCT04920123 | Serious Game-based ...
This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.
Effectiveness of a Serious Game for Cognitive Training in ...
We aim to demonstrate the preliminary therapeutic effectiveness of Neuro-World, serious mobile games for cognitive training, in chronic stroke survivors.
Serious Game-based Intervention for Mild Cognitive Impairment
Research shows that serious games, like Neuro-World, can improve cognitive function in people with mild cognitive impairment. Studies found that similar game- ...
Official Study Title: Towards the development of a mobile- ...
The goal of this research study is 1) to study the effectiveness of routinely playing Neuro-World cognitive training games in improving your ...
Mobile-health technology - NIH RePORTER
We plan to employ a tablet-based application – namely Neuro-World – composed of six serious games designed to stimulate working memory and selective attention, ...
Effects of Home-Based Computerized Cognitive Training in ...
The results of this study indicated that the HB-CCT performed in community-dwelling adults with MCI improved cognitive function and reduced depression levels ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.